In the evaluation of HER2-positive and HER2-negative breast cancer, the senior radiologist (Radiologist 1) exhibited improvements in the AUC, sensitivity, specificity, and accuracy by 0.22, 0.07, 0.16, and 0.14, respectively (Figure 2E; Table 3). Here, ERBB2 is linked to breast carcinoma.